Concepts (183)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Eosinophilic Esophagitis | 7 | 2019 | 22 | 3.080 |
Why?
|
| Gastroesophageal Reflux | 8 | 2017 | 121 | 1.630 |
Why?
|
| Proton Pump Inhibitors | 5 | 2019 | 34 | 1.230 |
Why?
|
| Deglutition Disorders | 5 | 2024 | 126 | 1.140 |
Why?
|
| Peptic Ulcer | 2 | 2019 | 18 | 1.130 |
Why?
|
| Esophageal Achalasia | 4 | 2020 | 61 | 0.950 |
Why?
|
| Esophageal Sphincter, Lower | 4 | 2024 | 32 | 0.940 |
Why?
|
| Monitoring, Ambulatory | 2 | 2016 | 32 | 0.860 |
Why?
|
| Hemostasis, Endoscopic | 1 | 2024 | 16 | 0.850 |
Why?
|
| Esophageal pH Monitoring | 5 | 2016 | 12 | 0.770 |
Why?
|
| Anti-Bacterial Agents | 2 | 2019 | 836 | 0.740 |
Why?
|
| Budesonide | 2 | 2019 | 46 | 0.730 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2024 | 242 | 0.710 |
Why?
|
| Esophagoscopy | 3 | 2018 | 91 | 0.690 |
Why?
|
| Esophagus | 4 | 2016 | 113 | 0.670 |
Why?
|
| Dilatation | 3 | 2016 | 47 | 0.660 |
Why?
|
| Helicobacter Infections | 2 | 2019 | 36 | 0.650 |
Why?
|
| Helicobacter pylori | 2 | 2019 | 36 | 0.650 |
Why?
|
| Esophagitis | 2 | 2016 | 40 | 0.590 |
Why?
|
| Manometry | 5 | 2024 | 42 | 0.560 |
Why?
|
| Esophageal Stenosis | 2 | 2015 | 25 | 0.550 |
Why?
|
| Anti-Ulcer Agents | 1 | 2018 | 22 | 0.550 |
Why?
|
| Laryngopharyngeal Reflux | 1 | 2017 | 2 | 0.540 |
Why?
|
| Malus | 1 | 2017 | 2 | 0.540 |
Why?
|
| Weight Loss | 2 | 2016 | 234 | 0.500 |
Why?
|
| Esophageal Mucosa | 1 | 2016 | 4 | 0.500 |
Why?
|
| Cough | 2 | 2016 | 56 | 0.490 |
Why?
|
| Telemetry | 1 | 2016 | 30 | 0.490 |
Why?
|
| Mediastinal Diseases | 1 | 2016 | 22 | 0.480 |
Why?
|
| Granuloma | 1 | 2016 | 64 | 0.480 |
Why?
|
| Enteropathy-Associated T-Cell Lymphoma | 1 | 2015 | 2 | 0.460 |
Why?
|
| Consensus | 1 | 2017 | 368 | 0.440 |
Why?
|
| Intestinal Neoplasms | 1 | 2015 | 68 | 0.430 |
Why?
|
| Diarrhea | 1 | 2015 | 179 | 0.420 |
Why?
|
| Esophageal Motility Disorders | 2 | 2024 | 17 | 0.420 |
Why?
|
| Fluticasone | 4 | 2019 | 31 | 0.390 |
Why?
|
| Humans | 33 | 2024 | 93511 | 0.380 |
Why?
|
| Decision Trees | 1 | 2012 | 64 | 0.370 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 154 | 0.360 |
Why?
|
| Practice Guidelines as Topic | 2 | 2017 | 1053 | 0.350 |
Why?
|
| Endoscopy, Digestive System | 3 | 2016 | 72 | 0.310 |
Why?
|
| Fundoplication | 4 | 2017 | 73 | 0.300 |
Why?
|
| Portasystemic Shunt, Surgical | 1 | 2008 | 10 | 0.280 |
Why?
|
| Hyperammonemia | 1 | 2008 | 14 | 0.280 |
Why?
|
| Steroids | 2 | 2019 | 168 | 0.270 |
Why?
|
| Brain Edema | 1 | 2008 | 58 | 0.270 |
Why?
|
| Adult | 15 | 2024 | 27918 | 0.250 |
Why?
|
| Liver Cirrhosis | 1 | 2008 | 273 | 0.240 |
Why?
|
| Gastrointestinal Agents | 2 | 2018 | 181 | 0.240 |
Why?
|
| Electric Impedance | 3 | 2016 | 115 | 0.230 |
Why?
|
| Precancerous Conditions | 1 | 2006 | 205 | 0.220 |
Why?
|
| Pharmacogenetics | 2 | 2019 | 456 | 0.220 |
Why?
|
| Glucocorticoids | 2 | 2018 | 362 | 0.220 |
Why?
|
| Peptic Ulcer Hemorrhage | 1 | 2024 | 10 | 0.220 |
Why?
|
| Single-Blind Method | 2 | 2015 | 159 | 0.200 |
Why?
|
| Cannabis | 1 | 2024 | 38 | 0.200 |
Why?
|
| Prospective Studies | 5 | 2016 | 4560 | 0.200 |
Why?
|
| Male | 17 | 2024 | 44553 | 0.200 |
Why?
|
| Diabetes Complications | 1 | 2024 | 170 | 0.190 |
Why?
|
| Female | 17 | 2024 | 48698 | 0.180 |
Why?
|
| Predictive Value of Tests | 3 | 2016 | 1713 | 0.180 |
Why?
|
| Hospitalization | 2 | 2020 | 937 | 0.170 |
Why?
|
| Middle Aged | 14 | 2024 | 27569 | 0.170 |
Why?
|
| Disease Management | 2 | 2020 | 358 | 0.170 |
Why?
|
| Peristalsis | 1 | 2020 | 10 | 0.170 |
Why?
|
| Treatment Outcome | 7 | 2018 | 9098 | 0.160 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2006 | 646 | 0.150 |
Why?
|
| Colonoscopy | 2 | 2015 | 303 | 0.150 |
Why?
|
| Colectomy | 1 | 2020 | 192 | 0.150 |
Why?
|
| Sleep Wake Disorders | 1 | 2020 | 124 | 0.150 |
Why?
|
| Interleukin-13 | 1 | 2019 | 41 | 0.140 |
Why?
|
| Prescription Drugs | 1 | 2019 | 38 | 0.140 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2715 | 0.140 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2016 | 493 | 0.140 |
Why?
|
| Colorectal Neoplasms | 1 | 2006 | 1053 | 0.140 |
Why?
|
| Proton Pumps | 1 | 2017 | 4 | 0.140 |
Why?
|
| Americas | 1 | 2017 | 19 | 0.130 |
Why?
|
| Hypopharynx | 1 | 2017 | 9 | 0.130 |
Why?
|
| Laparoscopy | 4 | 2017 | 782 | 0.130 |
Why?
|
| Diet, Mediterranean | 1 | 2017 | 6 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2016 | 1161 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2019 | 150 | 0.130 |
Why?
|
| Asia | 1 | 2017 | 107 | 0.130 |
Why?
|
| Barrett Esophagus | 1 | 2018 | 94 | 0.130 |
Why?
|
| Climate | 1 | 2017 | 61 | 0.130 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 1917 | 0.130 |
Why?
|
| Aged | 8 | 2024 | 20430 | 0.130 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 249 | 0.120 |
Why?
|
| Europe | 1 | 2017 | 337 | 0.120 |
Why?
|
| Attitude to Health | 1 | 2018 | 217 | 0.120 |
Why?
|
| Hoarseness | 1 | 2016 | 11 | 0.120 |
Why?
|
| Transducers | 1 | 2016 | 37 | 0.120 |
Why?
|
| Itraconazole | 1 | 2016 | 12 | 0.120 |
Why?
|
| Clinical Decision-Making | 1 | 2019 | 291 | 0.120 |
Why?
|
| Biological Products | 1 | 2019 | 178 | 0.120 |
Why?
|
| Food, Formulated | 1 | 2016 | 25 | 0.120 |
Why?
|
| Respiratory Sounds | 1 | 2016 | 39 | 0.120 |
Why?
|
| Urban Population | 1 | 2017 | 234 | 0.120 |
Why?
|
| Catheters | 1 | 2016 | 96 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2017 | 162 | 0.120 |
Why?
|
| Mucous Membrane | 2 | 2014 | 82 | 0.120 |
Why?
|
| Dexlansoprazole | 1 | 2015 | 1 | 0.120 |
Why?
|
| Esophagoplasty | 1 | 2015 | 9 | 0.120 |
Why?
|
| Antifungal Agents | 1 | 2016 | 122 | 0.120 |
Why?
|
| Esophageal Neoplasms | 1 | 2018 | 344 | 0.110 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2018 | 292 | 0.110 |
Why?
|
| Food Hypersensitivity | 1 | 2016 | 79 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2016 | 1546 | 0.110 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2016 | 289 | 0.110 |
Why?
|
| Sex Factors | 1 | 2017 | 1105 | 0.100 |
Why?
|
| Genome, Human | 1 | 2019 | 823 | 0.100 |
Why?
|
| Crohn Disease | 1 | 2020 | 808 | 0.100 |
Why?
|
| Hernia, Hiatal | 1 | 2013 | 35 | 0.100 |
Why?
|
| Age Factors | 1 | 2017 | 1906 | 0.100 |
Why?
|
| Tennessee | 1 | 2012 | 15 | 0.090 |
Why?
|
| Acoustics | 1 | 2012 | 46 | 0.090 |
Why?
|
| Antibodies, Monoclonal | 1 | 2019 | 1395 | 0.090 |
Why?
|
| Patient Selection | 1 | 2016 | 690 | 0.090 |
Why?
|
| Oliguria | 1 | 2012 | 6 | 0.090 |
Why?
|
| Metered Dose Inhalers | 1 | 2012 | 33 | 0.090 |
Why?
|
| Urinary Bladder Diseases | 1 | 2012 | 42 | 0.090 |
Why?
|
| Androstadienes | 1 | 2012 | 72 | 0.090 |
Why?
|
| Ascites | 1 | 2012 | 54 | 0.090 |
Why?
|
| Creatinine | 1 | 2012 | 293 | 0.090 |
Why?
|
| Biopsy | 1 | 2015 | 1175 | 0.090 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2012 | 160 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2018 | 1173 | 0.080 |
Why?
|
| Self Report | 1 | 2012 | 328 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 1799 | 0.080 |
Why?
|
| Young Adult | 3 | 2020 | 6930 | 0.080 |
Why?
|
| Urinary Bladder | 1 | 2012 | 260 | 0.080 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2012 | 353 | 0.080 |
Why?
|
| Logistic Models | 1 | 2012 | 1243 | 0.070 |
Why?
|
| Retrospective Studies | 4 | 2024 | 10164 | 0.070 |
Why?
|
| Research Design | 1 | 2012 | 617 | 0.070 |
Why?
|
| Disease Progression | 2 | 2018 | 1531 | 0.070 |
Why?
|
| Pharmacogenomic Testing | 2 | 2019 | 107 | 0.070 |
Why?
|
| Risk Factors | 3 | 2020 | 5898 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2012 | 1847 | 0.060 |
Why?
|
| Biomarkers, Tumor | 1 | 2015 | 1660 | 0.060 |
Why?
|
| Population Surveillance | 1 | 2006 | 213 | 0.060 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 2585 | 0.060 |
Why?
|
| Precision Medicine | 2 | 2019 | 456 | 0.050 |
Why?
|
| Biomarkers | 2 | 2012 | 1910 | 0.050 |
Why?
|
| Diabetic Neuropathies | 1 | 2024 | 42 | 0.050 |
Why?
|
| Dronabinol | 1 | 2024 | 58 | 0.050 |
Why?
|
| Recurrence | 2 | 2016 | 1190 | 0.050 |
Why?
|
| Surveys and Questionnaires | 2 | 2019 | 2802 | 0.040 |
Why?
|
| Drug Recalls | 1 | 2019 | 12 | 0.040 |
Why?
|
| Follow-Up Studies | 2 | 2016 | 3828 | 0.040 |
Why?
|
| Esomeprazole | 1 | 2018 | 2 | 0.040 |
Why?
|
| Aged, 80 and over | 2 | 2020 | 7061 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 876 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2020 | 889 | 0.030 |
Why?
|
| Prednisone | 1 | 2018 | 242 | 0.030 |
Why?
|
| Guidelines as Topic | 1 | 2019 | 163 | 0.030 |
Why?
|
| Point-of-Care Systems | 1 | 2019 | 150 | 0.030 |
Why?
|
| Research | 1 | 2019 | 251 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 3054 | 0.030 |
Why?
|
| Diabetes Mellitus | 1 | 2024 | 767 | 0.030 |
Why?
|
| Perception | 1 | 2018 | 179 | 0.030 |
Why?
|
| Health Personnel | 1 | 2019 | 234 | 0.030 |
Why?
|
| Adolescent | 2 | 2020 | 9606 | 0.030 |
Why?
|
| Remission Induction | 1 | 2018 | 738 | 0.030 |
Why?
|
| Dilatation, Pathologic | 1 | 2016 | 51 | 0.030 |
Why?
|
| Sleep | 1 | 2020 | 448 | 0.030 |
Why?
|
| Italy | 1 | 2016 | 110 | 0.030 |
Why?
|
| Communication | 1 | 2019 | 434 | 0.030 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2017 | 133 | 0.030 |
Why?
|
| Illinois | 1 | 2016 | 520 | 0.030 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2018 | 920 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2017 | 298 | 0.030 |
Why?
|
| Physician-Patient Relations | 1 | 2019 | 576 | 0.030 |
Why?
|
| Body Mass Index | 1 | 2016 | 811 | 0.020 |
Why?
|
| Prognosis | 1 | 2020 | 3910 | 0.020 |
Why?
|
| Rupture | 1 | 2012 | 59 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2018 | 1001 | 0.020 |
Why?
|
| Infant | 1 | 2018 | 3220 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2018 | 3829 | 0.020 |
Why?
|
| Wounds, Nonpenetrating | 1 | 2012 | 114 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 2440 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2012 | 283 | 0.020 |
Why?
|
| Child | 1 | 2018 | 7355 | 0.020 |
Why?
|